您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览211 | 下载92

Colon cancer is one of the most common cancers in China, with an increasing incidence these years. Currently, the combined therapy based on radical surgery has dramatically improved the survival rate and life quality of patients, however, a large percentage of patients still died of recurrence and metastasis. In recent years, the treatment strategies for the recurrence of colon cancer have been greatly advanced, especially the new targeted drugs and chemotherapeutic drugs, which lead to a significantly improved therapeutic efficacy and a better life quality. Therefore, how to choose and use these new treatments synthetically and reasonably become a great challenge to all surgeons, especially to digestive surgeons.

作者:顾晋;杜长征

来源:中华消化外科杂志 2008 年 7卷 3期

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:211 | 下载:92
作者:
顾晋;杜长征
来源:
中华消化外科杂志 2008 年 7卷 3期
标签:
结肠肿瘤 复发 Colon cancer Recurrence
Colon cancer is one of the most common cancers in China, with an increasing incidence these years. Currently, the combined therapy based on radical surgery has dramatically improved the survival rate and life quality of patients, however, a large percentage of patients still died of recurrence and metastasis. In recent years, the treatment strategies for the recurrence of colon cancer have been greatly advanced, especially the new targeted drugs and chemotherapeutic drugs, which lead to a significantly improved therapeutic efficacy and a better life quality. Therefore, how to choose and use these new treatments synthetically and reasonably become a great challenge to all surgeons, especially to digestive surgeons.